EMG
BIND

Ellington Management Group’s BIND THERAPEUTICS INC BIND Stock Holding History

Ellington Management Group’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-18,638
Closed -$104K – 1062
2015
Q2 		$104K Buy
+18,638
New +$116K 0.03% 649

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ellington Management Group's BIND Position: Q3 2015 in Review

Ellington Management Group sold out of BIND THERAPEUTICS INC (BIND) in Q3 2015, closing a stake of 18,638 shares — an estimated $104K sold.

Ellington Management Group first reported a position in BIND in Q2 2015 and held it in 1 quarter. The position peaked at $104K in Q2 2015. 33 funds tracked by Wall St. Rank hold BIND as of Q3 2015.

  • Ellington Management Group reported no remaining BIND THERAPEUTICS INC position as of Q3 2015 after selling out during the quarter.
  • Ellington Management Group sold 18,638 BIND THERAPEUTICS INC shares in Q3 2015, an estimated $104K.
  • Ellington Management Group first reported a position in BIND THERAPEUTICS INC in Q2 2015 and held it in 1 quarter.
  • Ellington Management Group's BIND THERAPEUTICS INC position peaked at $104K in Q2 2015.
  • 33 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2015.

Based on Ellington Management Group's 13F filing for Q3 2015, filed 16 Nov 2015.